2023
DOI: 10.3324/haematol.2022.281580
|View full text |Cite
|
Sign up to set email alerts
|

Germline loss of function <i>BRCA1</i> and <i>BRCA2</i> mutations and risk of <i>de novo</i> hematopoietic malignancies

Abstract: Not available.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…BRCA mutations are associated with an increased risk of breast/ovarian cancers and other solid tumors [19,20]. There are few reports indicating an association between BRCA mutations and hematological malignancies [20,21]. In a study by Yin et al, they presented a new BRCA2 mutation, c.8434_8435insTT, associated with multiple hematological malignancies and solid tumors in a single family [20].…”
Section: Discussionmentioning
confidence: 99%
“…BRCA mutations are associated with an increased risk of breast/ovarian cancers and other solid tumors [19,20]. There are few reports indicating an association between BRCA mutations and hematological malignancies [20,21]. In a study by Yin et al, they presented a new BRCA2 mutation, c.8434_8435insTT, associated with multiple hematological malignancies and solid tumors in a single family [20].…”
Section: Discussionmentioning
confidence: 99%